485.8000 4.45 (0.92%)
NSE Apr 10, 2026 15:31 PM
Volume: 64,490
 

485.80
0.92%
Axis Direct
Considering overall stellar performance we have incresed earnings for FY22E & FY23E and increased target price to INR 1,670 with Buy recommendations.
Promoters unpledged 9.28% of shares in last quarter. Total pledge stands at 26.04% of promoter holdings
More from Solara Active Pharma Sciences Ltd.
Recommended